AMSG
AmSurg Corp
Set alert
67.75 0.00 0.00%
67.12 Day range 70.09
57.32 52-week range 84.71
- Open
- 68.12
- Prev close
- 67.75
- Mkt cap
- 0
- Vol
- 22.17M
- Avg vol
- 1.04M
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 67.12
- High
- 70.09
- Earnings
- Nov 1, 2016
Next earnings
Nov 1, 2016
Expected Nov 1, 2016. Consensus EPS estimate 1.04.
Financials — quick view
AMSG Revenue — quarterly 822.22M
AMSG Net income — quarterly 39.95M
AMSG EPS — quarterly 0.70
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 1, 2016 | Sep 1, 2016 | 1.04 | — | — | — |
| Aug 2, 2016 | Jun 1, 2016 | 1.02 | — | — | — |
| May 3, 2016 | Mar 1, 2016 | 0.74 | — | — | — |
| Feb 24, 2016 | Dec 1, 2015 | 1.00 | — | — | — |
| Nov 3, 2015 | Sep 1, 2015 | 0.91 | — | — | — |
| Aug 4, 2015 | Jun 1, 2015 | 0.80 | — | — | — |
News
- AMSURG Reports Third-Quarter Diluted EPS of $0.69 and Adjusted Diluted EPS of $1.13
- UBS Sees $43-$44 Deal Value For Potential TeamHealth Sale
- Benzinga's M&A Chatter for Tuesday October 4, 2016
- AMSURG Announces Second-Quarter Financial Results
- TeamHealth Management Unfazed By Envision-AmSurg Deal
- Benzinga's M&A Chatter for Wednesday June 8, 2016
- AmSurg Announces 27% Growth in First-Quarter Net Revenues, with Strong Same-Center and Same-Contract Revenue Growth
- JP Morgan Downgrades Team Health To Neutral Amid Recent Upside
- AmSurg Reports 21% Growth in Fourth-Quarter Net Revenues, 39% Growth in Adjusted Diluted EPS of $1.07 and Diluted EPS of $1.26
- AmSurg Reports Third-Quarter Adjusted Diluted EPS of $1.03 and Diluted EPS of $0.83
Your note
Sign in to keep a note on AMSG — it syncs with the Stock Master app.